首页> 外文会议>Imaging, manipulation, and analysis of biomolecules, cells, and tissues XI >Kinetic identification of protein ligands in a 51,200 small-molecule library using microarrays and a label-free ellipsometric scanner
【24h】

Kinetic identification of protein ligands in a 51,200 small-molecule library using microarrays and a label-free ellipsometric scanner

机译:使用微阵列和无标记椭偏扫描仪对51,200个小分子文库中的蛋白质配体进行动力学鉴定

获取原文
获取原文并翻译 | 示例

摘要

Drug discovery begins by identifying protein-small molecule binding pairs. Afterwards, binding kinetics and biofunctional assays are performed, to reduce candidates for further development. High-throughput screening, typically employing fluorescence, is widely used to find protein ligands in small-molecule libraries, but is rarely used for binding kinetics measurement because: (1) attaching fluorophores to proteins can alter kinetics and (2) most label-free technologies for kinetics measurement are inherently low-throughput and consume expensive sensing surfaces. We addressed this need with polarization-modulated ellipsometric scanning microscopes, called oblique-incidence reflectivity difference (OI-RD). Label-free ligand screening and kinetics measurement are performed simultaneously on small-molecule microarrays printed on relatively inexpensive isocyanate-functionalized glass slides. As a microarray is reacted, an OI-RD microscope tracks the change in surface-bound macromolecule density in real-time at every spot. We report progress applying OI-RD to screen purified proteins and virus particles against a 51,200-compound library from the National Cancer Institute. Four microarrays, each containing 12,800 library compounds, are installed in four flow cells in an automated OI-RD microscope. The slides are reacted serially, each giving 12,800 binding curves with ~30 sec time resolution. The entire library is kinetically screened against a single probe in ~14 hours and multiple probes can be reacted sequentially under automation. Real-time binding detection identifies both high-affinity and low-affinity (transient binding) interactions; fluorescence endpoint images miss the latter. OI-RD and microarrays together is a powerful high-throughput tool for early stage drug discovery and development. The platform also has great potential for downstream steps such as in vitro inhibition assays.
机译:药物发现始于鉴定蛋白质-小分子结合对。之后,进行结合动力学和生物功能测定,以减少进一步开发的候选物。高通量筛选(通常使用荧光)被广泛用于在小分子文库中查找蛋白质配体,但很少用于结合动力学测量,因为:(1)将荧光团附着到蛋白质上可以改变动力学,并且(2)多数无标记动力学测量技术本质上是低通量的,并且消耗昂贵的传感表面。我们使用偏振调制椭圆偏振扫描显微镜(称为斜入射反射率差(OI-RD))解决了这一需求。在标记于相对便宜的异氰酸酯官能化的载玻片上的小分子微阵列上同时进行无标记配体筛选和动力学测量。当微阵列反应时,OI-RD显微镜实时跟踪每个位置上表面结合的大分子密度的变化。我们报告了应用OI-RD筛选来自国家癌症研究所的51,200化合物库的纯化蛋白和病毒颗粒的进展。在自动OI-RD显微镜的四个流通池中安装了四个微阵列,每个微阵列包含12,800个文库化合物。载玻片进行连续反应,每个载玻片给出12800条结合曲线,时间分辨率约为30秒。整个文库在约14小时内针对单个探针进行了动力学筛选,多个探针可以在自动化条件下顺序反应。实时绑定检测可识别高亲和力和低亲和力(瞬态绑定)相互作用。荧光终点图像错过了后者。 OI-RD和微阵列一起是用于早期药物发现和开发的强大的高通量工具。该平台还具有很大的潜力,可用于下游步骤,例如体外抑制试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号